摘要
充血性心力衰竭是各 种心脏病的终末阶段,其预后较差。近20年来充血性心力衰竭的治疗进入神经体液调节时代。在洋地黄、利尿药和血管扩张药的基础上,使用血管紧张素转换酶抑制药、β受体阻断剂、醛固酮拮抗剂等,已取得初步成功,但尚未根本改变充血性心力衰竭的预后。
Congestiveheart failure (CHF) is the end stage of various heart dis-eases with poor prognosis. In recent 20 years, the CHF has entered into the er ea of adjusting neurohormone. On basis of digitalis , diuretics and vasodilator, the widespread use of ACEI, β-receptor blocker and aldosterone antagonist has achieved prelin minary success. But the poor prognosis of CHF has not yet been changed thoroughly.
出处
《当代医学》
2000年第6期23-26,共4页
Contemporary Medicine
关键词
充血性心力衰竭
洋地黄
利尿药
血管扩张药
congestive heart failure, digitalis, diuretics, vasodilator, ACEI, aldosterone antagonist, β- receptor blocker
